These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 1647917

  • 21. Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy.
    Dufresne SS, Boulanger-Piette A, Bossé S, Argaw A, Hamoudi D, Marcadet L, Gamu D, Fajardo VA, Yagita H, Penninger JM, Russell Tupling A, Frenette J.
    Acta Neuropathol Commun; 2018 Apr 24; 6(1):31. PubMed ID: 29699580
    [Abstract] [Full Text] [Related]

  • 22. Creatine kinase, cell membrane and Duchenne muscular dystrophy.
    Ozawa E, Hagiwara Y, Yoshida M.
    Mol Cell Biochem; 1999 Jan 24; 190(1-2):143-51. PubMed ID: 10098981
    [Abstract] [Full Text] [Related]

  • 23. An examination of some factors influencing creatine kinase in the blood of patients with muscular dystrophy.
    Jackson MJ, Round JM, Newham DJ, Edwards RH.
    Muscle Nerve; 1987 Jan 24; 10(1):15-21. PubMed ID: 3561434
    [Abstract] [Full Text] [Related]

  • 24. Is the normal content of sulfhydryl groups attributable to sparing from dystrophic pathology in dystrophin-deficient muscles?
    Niebrój-Dobosz I, Fidziańska A, Glinka Z, Hausmanowa-Petrusewicz I.
    Folia Neuropathol; 2002 Jan 24; 40(3):143-50. PubMed ID: 12572920
    [Abstract] [Full Text] [Related]

  • 25. Myofibrillar creatine kinase in Duchenne and avian muscular dystrophy.
    Feit H, Fuseler J, Cook JD.
    Biochem Med; 1983 Jun 24; 29(3):355-9. PubMed ID: 6615491
    [Abstract] [Full Text] [Related]

  • 26. Decreased creatine kinase activity in cultured Duchenne dystrophic muscle cells.
    Iannaccone ST, Nagy B, Samaha FJ.
    J Child Neurol; 1987 Jan 24; 2(1):17-21. PubMed ID: 3624824
    [Abstract] [Full Text] [Related]

  • 27. Development and specialization in muscle and the biochemistry of the dystrophies.
    Perry SV.
    J Neurol Sci; 1971 Mar 24; 12(3):289-306. PubMed ID: 5550262
    [No Abstract] [Full Text] [Related]

  • 28. Inhibition of Ca2+-induced cytosolic enzyme efflux from skeletal muscle by vitamin E and related compounds.
    Phoenix J, Edwards RH, Jackson MJ.
    Biochem J; 1989 Jan 01; 257(1):207-13. PubMed ID: 2493242
    [Abstract] [Full Text] [Related]

  • 29. Serum CK, calcium, magnesium, and oxidative phosphorylation in mdx mouse muscular dystrophy.
    Glesby MJ, Rosenmann E, Nylen EG, Wrogemann K.
    Muscle Nerve; 1988 Aug 01; 11(8):852-6. PubMed ID: 3173410
    [Abstract] [Full Text] [Related]

  • 30. Protein synthesis in muscle cultures from patients with Duchenne muscular dystrophy. Calcium and A23187 ionophore dependent changes.
    Ionasescu V, Zellweger H, Ionasescu R, Lara-Braud C, Cancilla PA.
    Acta Neurol Scand; 1976 Sep 01; 54(3):241-7. PubMed ID: 785934
    [Abstract] [Full Text] [Related]

  • 31. An injury model myopathy mimicking dystrophy: implications regarding the function of dystrophin.
    Stauber WT, Fritz VK, Clarkson PM, Riggs JE.
    Med Hypotheses; 1991 Aug 01; 35(4):358-62. PubMed ID: 1943889
    [Abstract] [Full Text] [Related]

  • 32. Muscle calcium and magnesium content in Duchenne muscular dystrophy.
    Bertorini TE, Bhattacharya SK, Palmieri GM, Chesney CM, Pifer D, Baker B.
    Neurology; 1982 Oct 01; 32(10):1088-92. PubMed ID: 6889695
    [Abstract] [Full Text] [Related]

  • 33. Treatment with human immunoglobulin G improves the early disease course in a mouse model of Duchenne muscular dystrophy.
    Zschüntzsch J, Zhang Y, Klinker F, Makosch G, Klinge L, Malzahn D, Brinkmeier H, Liebetanz D, Schmidt J.
    J Neurochem; 2016 Jan 01; 136(2):351-62. PubMed ID: 26230042
    [Abstract] [Full Text] [Related]

  • 34. Whole-body clearing, staining and screening of calcium deposits in the mdx mouse model of Duchenne muscular dystrophy.
    Bozycki L, Łukasiewicz K, Matryba P, Pikula S.
    Skelet Muscle; 2018 Jul 19; 8(1):21. PubMed ID: 30025544
    [Abstract] [Full Text] [Related]

  • 35. Effects of cocaine on leakage of creatine kinase from skeletal muscle: in vitro and in vivo studies in mice.
    Brazeau GA, McArdle A, Jackson MJ.
    Life Sci; 1995 Jul 19; 57(17):1569-78. PubMed ID: 7564904
    [Abstract] [Full Text] [Related]

  • 36. Duchenne muscular dystrophy: adenosine triphosphate and creatine phosphate content in muscle.
    Samaha FJ, Davis B, Nagy B.
    Neurology; 1981 Jul 19; 31(7):916-9. PubMed ID: 7195521
    [Abstract] [Full Text] [Related]

  • 37. Isoenzyme distribution of creatine kinase and lactate dehydrogenase in serum and skeletal muscle in Duchenne muscular dystrophy, collagen disease, and other muscular disorders.
    Yasmineh WG, Ibrahim GA, Abbasnezhad M, Awad EA.
    Clin Chem; 1978 Nov 19; 24(11):1985-9. PubMed ID: 709832
    [Abstract] [Full Text] [Related]

  • 38. Natural disease history of the dy2J mouse model of laminin α2 (merosin)-deficient congenital muscular dystrophy.
    Pasteuning-Vuhman S, Putker K, Tanganyika-de Winter CL, Boertje-van der Meulen JW, van Vliet L, Overzier M, Plomp JJ, Aartsma-Rus A, van Putten M.
    PLoS One; 2018 Nov 19; 13(5):e0197388. PubMed ID: 29763467
    [Abstract] [Full Text] [Related]

  • 39. Independent pathways causing cellular damage in mouse soleus muscle under hypoxia.
    McCall KE, Duncan CJ.
    Comp Biochem Physiol A Comp Physiol; 1989 Nov 19; 94(4):799-804. PubMed ID: 2575965
    [Abstract] [Full Text] [Related]

  • 40. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
    Capogrosso RF, Mantuano P, Cozzoli A, Sanarica F, Massari AM, Conte E, Fonzino A, Giustino A, Rolland JF, Quaranta A, De Bellis M, Camerino GM, Grange RW, De Luca A.
    J Appl Physiol (1985); 2017 Apr 01; 122(4):828-843. PubMed ID: 28057817
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.